Community consensus for Heparan sulfate as a biomarker to support accelerated approval in Neuronopathic Mucopolysaccharidoses.
- DOI
- 10.1016/j.ymgme.2024.108535
- Published
- 2024 Aug
- Container
- Molecular genetics and metabolism
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ymgme.2024.108535,
title = {Community consensus for Heparan sulfate as a biomarker to support accelerated approval in Neuronopathic Mucopolysaccharidoses.},
author = {Muenzer J and Ho C and Lau H and Dant M and Fuller M and Boulos N and Dickson P and Ellinwood NM and Jones SA and Zanelli E and O'Neill C},
year = {2024},
journal = {Molecular genetics and metabolism},
doi = {10.1016/j.ymgme.2024.108535},
url = {https://doi.org/10.1016/j.ymgme.2024.108535}
}RIS
TY - JOUR TI - Community consensus for Heparan sulfate as a biomarker to support accelerated approval in Neuronopathic Mucopolysaccharidoses. AU - Muenzer J AU - Ho C AU - Lau H AU - Dant M AU - Fuller M AU - Boulos N AU - Dickson P AU - Ellinwood NM AU - Jones SA AU - Zanelli E AU - O'Neill C PY - 2024 JO - Molecular genetics and metabolism DO - 10.1016/j.ymgme.2024.108535 UR - https://doi.org/10.1016/j.ymgme.2024.108535 ER -
APA
J, M., C, H., H, L., M, D., M, F., N, B., P, D., NM, E., SA, J., E, Z., & C, O. (2024). Community consensus for Heparan sulfate as a biomarker to support accelerated approval in Neuronopathic Mucopolysaccharidoses.. Molecular genetics and metabolism. https://doi.org/10.1016/j.ymgme.2024.108535
Source records
- pubmed · retrieved 2026-09-27T00:20:58.155Z